IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA
IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA
Read moreIP Group's Artios Lands Bumper Oncology Pact With Merck KGaA
Read more(Sharecast News) - IP Group said its Artios portfolio company had signed a research deal with Merck of Germany that could more than double the value of the investment company's stake.
Read moreUK WINNERS & LOSERS SUMMARY: SSE Rises On Energy-From-Waste Sale
Read moreIP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress
Read more(Sharecast News) - Intellectual property-based business investor IP Group announced on Tuesday that its portfolio company Oxford Nanopore Technologies has raised an additional £84.4m of new capital from existing and new investors, including International Holdings Company (IHC) and RPMI Railpen.
Read moreIP Group Notes CE Mark For Oxford Nanopore's LamPORE Covid-19 Test
Read more(Sharecast News) - Intellectual property company IP Group said on Wednesday that portfolio group Enterprise Therapeutics' TMEM16A cystic fibrosis treatment programme had been acquired by Swiss pharmaceutical giant Roche.
Read moreTOP NEWS: IP Group Notes Roche's Enterprise Therapeutics Program Buy
Read moreLONDON BRIEFING: Tesco Profits Surge Amid Stocking Up By Consumers
Read moreLONDON MARKET PRE-OPEN: Tesco Lifts Interim Payout 21% As Profit Rises
Read moreUK BROKER RATINGS SUMMARY: RBC Upgrades Hastings To Sector Perform
Read moreUK BROKER RATINGS SUMMARY: Liberum Says Buy XP Power, Cuts PageGroup
Read moreIP Group Net Asset Value Declines Amid Record Cash Realisations
Read more(Sharecast News) - IP Group reported net portfolio gains of £34.9m, or 3%, in its first half on Wednesday, with cash realisations rising to £113.7m from £7.1m a year earlier, exceeding investment by £76.9m.
Read moreLONDON MARKET CLOSE: Manufacturing PMIs Spark Strong Start To August
Read more